Turkey's Position Regarding Clinical Drug Trials
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2003 |
|---|---|
| Erschienen: |
2003 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Clinical research and regulatory affairs - 20(2003), 3, Seite 349-356 |
| Beteiligte Personen: |
Örnek Büken, Nüket [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
8 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1663046530 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1663046530 | ||
| 003 | DE-627 | ||
| 005 | 20230516114741.0 | ||
| 007 | tu | ||
| 008 | 040513s2003 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw040513 |
| 035 | |a (DE-627)OLC1663046530 | ||
| 035 | |a (DE-599)GBVOLC1663046530 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Örnek Büken, Nüket |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Turkey's Position Regarding Clinical Drug Trials |
| 264 | 1 | |c 2003 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 773 | 0 | 8 | |i Enthalten in |t Clinical research and regulatory affairs |d London : Informa Healthcare, 1992 |g 20(2003), 3, Seite 349-356 |w (DE-627)170766306 |w (DE-600)1102948-1 |x 1060-1333 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2003 |g number:3 |g pages:349-356 |g extent:8 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.00 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 20 |j 2003 |e 3 |h 349-356 |g 8 | ||